Denosumab reduces early migration in total knee replacement: A randomized controlled trial involving 50 patients

BACKGROUND AND PURPOSE: Aseptic loosening is a main cause of late revision in total knee replacement (TKR). Migration of implants as measured by radiostereometric analysis (RSA) can predict future loosening. This migration is associated with bone resorption. Denosumab is a human monoclonal antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: Ledin, Håkan, Good, Lars, Aspenberg, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Knee
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434591/
https://www.ncbi.nlm.nih.gov/pubmed/28287004
http://dx.doi.org/10.1080/17453674.2017.1300746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434591/
https://www.ncbi.nlm.nih.gov/pubmed/28287004
http://dx.doi.org/10.1080/17453674.2017.1300746

Ejemplares similares